Silencing MARCH1 suppresses proliferation, migration and invasion of ovarian cancer SKOV3 cells via downregulation of NF-κB and Wnt/β-catenin pathways

Oncology Reports

Volumn 36, Issue 5, 2016, Pages 2463-2470

  Meng, Ying ^a   Hu, Jianguo ^a   Chen, Yuhong ^a   Yu, Tinghe ^a   Hu, Lina ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

MARCH1; NF B; Ovarian cancer; RNAi; Wnt catenin

Indexed keywords

BETA CATENIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; WNT PROTEIN; MARCH1 PROTEIN, HUMAN; RELA PROTEIN, HUMAN; TRANSCRIPTION FACTOR RELA; UBIQUITIN PROTEIN LIGASE;

ADULT; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER TISSUE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MARCH1 GENE; ONCOGENE; OVARIAN CANCER CELL LINE; OVARIAN TISSUE; OVARY CANCER; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKOV3 CELL LINE; TRANSCRIPTION REGULATION; UPREGULATION; WESTERN BLOTTING; YOUNG ADULT; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; OVARY TUMOR; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION; WNT SIGNALING PATHWAY;

BETA CATENIN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; NEOPLASM INVASIVENESS; NF-KAPPA B; OVARIAN NEOPLASMS; TRANSCRIPTION FACTOR RELA; UBIQUITIN-PROTEIN LIGASES; WNT SIGNALING PATHWAY;

EID: 84989920872     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2016.5076     Document Type: Article

References (39)

1. Kandukuri SR and Rao J: FIGO 2013 staging system for ovarian cancer: What is new in comparison to the 1988 staging system? Curr Opin Obstet Gynecol 27: 48-52, 2015.
2. Tew WP and Fleming GF: Treatment of ovarian cancer in the older woman. Gynecol Oncol 136: 136-142, 2015.
3. Musto A, Grassetto G, Marzola MC, Rampin L, Chondrogiannis S, Maffione AM, Colletti PM, Perkins AC, Fagioli G and Rubello D: Management of epithelial ovarian cancer from diagnosis to restaging: An overview of the role of imaging techniques with particular regard to the contribution of 18F-FDG PET/CT. Nucl Med Commun 35: 588-597, 2014.
4. Nathan JA and Lehner PJ: The trafficking and regulation of membrane receptors by the RING-CH ubiquitin E3 ligases. Exp Cell Res 315: 1593-1600, 2009.
5. Ohmura-Hoshino M, Goto E, Matsuki Y, Aoki M, Mito M, Uematsu M, Hotta H and Ishido S: A novel family of membrane-bound E3 ubiquitin ligases. J Biochem 140: 147-154, 2006.
6. Jabbour M, Campbell EM, Fares H and Lybarger L: Discrete domains of MARCH1 mediate its localization, functional interactions, and posttranscriptional control of expression. J Immunol 183: 6500-6512, 2009.
7. Bourgeois-Daigneault MC and Thibodeau J: Identification of a novel motif that affects the conformation and activity of the MARCH1 E3 ubiquitin ligase. J Cell Sci 126: 989-998, 2013.
8. Corcoran K, Jabbour M, Bhagwandin C, Deymier MJ, Theisen DL and Lybarger L: Ubiquitin-mediated regulation of CD86 protein expression by the ubiquitin ligase membrane-associated RING-CH-1 (MARCH1). J Biol Chem 286: 37168-37180, 2011.
9. Tze LE, Horikawa K, Domaschenz H, Howard DR, Roots CM, Rigby RJ, Way DA, Ohmura-Hoshino M, Ishido S, Andoniou CE, et al: CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10-driven MARCH1-mediated ubiquitination and degradation. J Exp Med 208: 149-165, 2011.
10. Chattopadhyay G and Shevach EM: Antigen-specific induced T regulatory cells impair dendritic cell function via an IL-10/MARCH1-dependent mechanism. J Immunol 191: 5875-5884, 2013.
11. Bourgeois-Daigneault MC and Thibodeau J: Autoregulation of MARCH1 expression by dimerization and autoubiquitination. J Immunol 188: 4959-4970, 2012.
12. Matsuki Y, Ohmura-Hoshino M, Goto E, Aoki M, Mito-Yoshida M, Uematsu M, Hasegawa T, Koseki H, Ohara O, Nakayama M, et al: Novel regulation of MHC class II function in B cells. EMBO J 26: 846-854, 2007.
13. Chen R, Li M, Zhang Y, Zhou Q and Shu HB: The E3 ubiquitin ligase MARCH8 negatively regulates IL-1β-induced NF-κB activation by targeting the IL1RAP coreceptor for ubiquitination and degradation. Proc Natl Acad Sci USA 109: 14128-14133, 2012.
14. van de Kooij B, Verbrugge I, de Vries E, Gijsen M, Montserrat V, Maas C, Neefjes J and Borst J: Ubiquitination by the membrane-associated RING-CH-8 (MARCH-8) ligase controls steady-state cell surface expression of tumor necrosis factorrelated apoptosis inducing ligand (TRAIL) receptor 1. J Biol Chem 288: 6617-6628, 2013.
15. Hayden MS and Ghosh S: Signaling to NF-kappaB. Genes Dev 18: 2195-2224, 2004.
16. Fujita T, Nolan GP, Ghosh S and Baltimore D: Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B. Genes Dev 6: 775-787, 1992.
17. Woronicz JD, Gao X, Cao Z, Rothe M and Goeddel DV: IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK. Science 278: 866-869, 1997.
18. Schreck R, Albermann K and Baeuerle PA: Nuclear factor kappa B: An oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic Res Commun 17: 221-237, 1992.
19. Logan CY and Nusse R: The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20: 781-810, 2004.
20. Neth P, Ries C, Karow M, Egea V, Ilmer M and Jochum M: The Wnt signal transduction pathway in stem cells and cancer cells: Influence on cellular invasion. Stem Cell Rev 3: 18-29, 2007.
21. Katoh M and Katoh M: WNT signaling pathway and stem cell signaling network. Clin Cancer Res 13: 4042-4045, 2007.
22. Cheng CW, Wu PE, Yu JC, Huang CS, Yue CT, Wu CW and Shen CY: Mechanisms of inactivation of E-cadherin in breast carcinoma: Modification of the two-hit hypothesis of tumor suppressor gene. Oncogene 20: 3814-3823, 2001.
23. Berx G, Cleton-Jansen AM, Nollet F, de Leeuw WJ, van de Vijver M, Cornelisse C and van Roy F: E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 14: 6107-6115, 1995.
24. Gottardi CJ, Wong E and Gumbiner BM: E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner. J Cell Biol 153: 1049-1060, 2001.
25. Clevers H: Wnt/beta-catenin signaling in development and disease. Cell 127: 469-480, 2006.
26. Nelson WJ and Nusse R: Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303: 1483-1487, 2004.
27. Mantovani A, Allavena P, Sica A and Balkwill F: Cancer-related inflammation. Nature 454: 436-444, 2008.
28. Liotta LA and Kohn EC: The microenvironment of the tumourhost interface. Nature 411: 375-379, 2001.
29. Tak PP and Firestein GS: NF-kappaB: A key role in inflammatory diseases. J Clin Invest 107: 7-11, 2001.
30. Ghosh S, May MJ and Kopp EB: NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16: 225-260, 1998.
31. Van Antwerp DJ, Martin SJ, Kafri T, Green DR and Verma IM: Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 274: 787-789, 1996.
32. Micheau O, Lens S, Gaide O, Alevizopoulos K and Tschopp J: NF-kappaB signals induce the expression of c-FLIP. Mol Cell Biol 21: 5299-5305, 2001.
33. Thomas RP, Farrow BJ, Kim S, May MJ, Hellmich MR and Evers BM: Selective targeting of the nuclear factor-kappaB pathway enhances tumor necrosis factor-related apoptosisinducing ligand-mediated pancreatic cancer cell death. Surgery 132: 127-134, 2002.
34. Guttridge DC, Albanese C, Reuther JY, Pestell RG and Baldwin AS Jr: NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol 19: 5785-5799, 1999.
35. Chen F, Castranova V and Shi X: New insights into the role of nuclear factor-kappaB in cell growth regulation. Am J Pathol 159: 387-397, 2001.
36. Dolcet X, Llobet D, Pallares J and Matias-Guiu X: NF-kB in development and progression of human cancer. Virchows Arch 446: 475-482, 2005.
37. Sirotkin AV, Alexa R, KiŜová G, Harrath AH, Alwasel S, Ovcharenko D and Mlynček M: MicroRNAs control transcription factor NF-kB (p65) expression in human ovarian cells. Funct Integr Genomics 15: 271-275, 2015.
38. Cafferata EG, Guerrico AM, Pivetta OH and Santa-Coloma TA: NF-kappaB activation is involved in regulation of cystic fibrosis transmembrane conductance regulator (CFTR) by interleukin-1beta. J Biol Chem 276: 15441-15444, 2001.
39. Lu Z, Ghosh S, Wang Z and Hunter T: Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. Cancer Cell 4: 499-515, 2003.